Main content
Sorry, this episode is not currently available

Should the NHS pay for HIV drug Prep?

Deborah Gold, CEO of National Aids Trust, argues why Prep should be available on the NHS.

The High Court will rule today on who should pay for the HIV prevention drug Prep - the NHS or local authorities.

Deborah Gold, chief executive of the National Aids Trust, argues why Prep - which can costs 拢400 a month per person - should be available through the NHS.

(Image: HIV virus representation. Credit: Science Photo Library.)

9 minutes

More episodes

See all episodes from Best of Today

Podcast

  • Best of Today

    Listen to selected highlights from the Today programme.